A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics

Molecular Psychiatry

Volumn 3, Issue 4, 1998, Pages 328-332

  Malhotra, A K ^a,c   Goldman, D ^b   Mazzanti, C ^b   Clifton, A ^a   Breier, A ^a   Pickar, D ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

Gene; Hallucinations; Polymorphism; Psychosis; Schizophrenia; Serotonin

Indexed keywords

NEUROTRANSMITTER; SEROTONIN TRANSPORTER;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HALLUCINATION; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOSIS; RATING SCALE; SCHIZOIDISM; SCHIZOPHRENIA;

EID: 0031822689     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000412     Document Type: Article

References (27)

1. Gaddum JH. Drugs antagonistic to 5-hydroxytryptamine. In: Wolstenholme GW (eds). Ciba Foundation Symposium on Hypertension. Little Brown and Company: Boston, 1954, pp 75-77.
2. Wooley DW, Shaw E. A biochemical and pharmacological suggestion about certain mental disorders. Proc Natl Acad Sci USA 1954; 40: 228-231.
3. Fischman LG. Dreams, hallucinogenic drug states, and schizophrenia: a psychological and biological comparison. Schizophr Bull 1983; 9: 73-94.
4. Krystal JH, Seibyl JP, Price LH, Woods SW, Heninger GR, Aghajanian GK et al. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Arch Gen Psychiatry 1993; 50: 624-635.
5. Iqbal N, Asnis GM, Wetzler S, Kahn RS, Kay SR, van Praag HM. The MCPP challenge test in schizophrenia: hormonal and behavioral responses. Biol Psychiatry 1991; 30: 770-778.
6. Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE. Serotonin uptake sites and serotonin receptors are altered in limbic system of schizophrenics. Neuropsychopharmacology 1993; 8: 315-336.
7. Hashimoto T, Nishino N, Nakai H, Tanaka C. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Life Sci 1991; 48: 355-363.
8. Bennett JP, Enna SJ, Bylund DB, Gillin JC, Wyatt RJ, Snyder SH. Neurotransmitter receptors in frontal cortex of schizophrenics. Arch Gen Psychiatry 1979; 36: 927-934.
9. Arora RC, Meltzer HY. Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients. J Neural Transm Gen Sect 1991; 85: 19-29.
10. 2 receptors in chronic schizophrenics. Biol Psychiatry 1986; 21: 1407-1414.
11. Laruelle M, Abi-Dargham A, Casanova MF, Toti R, Weinberger DR, Kleinman JE. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. Arch Gen Psychiatry 1993; 50: 810-818.
12. Meltzer HY, Matsubara S, Lee J-C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine. J Pharmacol Exp Ther 1989; 251: 238-246.
13. Roth BL, Ciaranello RD, Meltzer HY. Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors. J Pharmacol Exp Ther 1992; 260: 1361-1365.
14. Watling KJ, Beer MS, Stanton JA, Newberry NR. Interaction of the atypical neuroleptic clozapine with 5-HT3 receptors in the cerebral cortex and superior cervical ganglion of the rat. Eur J Pharmacol 1990; 182: 465-472.
15. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D et al. Allelic variation of human serotonin transporter gone expression. J Neurochem 1996; 66: 2621-2624.
16. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531.
17. Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH. No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol Psychiatry 1997; 2: 224-226.
18. Overall JE, Gorham DP. The brief psychiatric rating scale. Psychol Rep 1962; 10: 799-812.
19. Hedlund JL, Vieweg BW. The brief psychiatric rating scale (BPRS): a comprehensive review. J Oper Psychiatr 1980; 11: 48-64.
20. Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P et al. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport 1996; 8: 1675-1679.
21. Bonnet-Brilhault F, Laurent C, Thibaut F, Campion D, Chavand O, Samolyk D et al. Serotonin transporter gene polymorphism and schizophrenia: an association study. Biol Psychiatry 1997; 42: 634-636.
22. Kendler KS, Karkowski-Shuman L, O'Neill FA, Straub RE, MacLean CJ, Walsh D. Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish Study of High-Density Schizophrenia Families: evidence for possible etiologic heterogeneity. Am J Psychiatry 1997; 154: 191-198.
23. DeLisi LE, Goldin LR, Gershon ES. Studies of biological factors associated with the inheritance of schizophrenia: a selective review. J Psychiat Res 1987; 21: 507-513.
24. Slater E. General cases of schizophrenic symptoms. Monatsschrift für Psychiatrie und Neurologie 1947; 113: 50-58.
25. Slater E. Psychotic and Neurotic Illnesses in Twins. Her Majesty's Stationery Office: London, 1953.
26. Bonson KR, Buckholtz JW, Murphy DL. Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans. Neuropsychopharmacology 1996; 14: 425-436.
27. Goff DC, Brotman AW, Waites M, McCormick S. Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients. Am J Psychiatry 1990; 147: 492-494.